Published in Vaccine Weekly, November 8th, 2000
"We hypothesized that HIV-1 specific CD4+ T helper immune responses could be enhanced when an immunostimulatory sequence (ISS) was combined with a whole-killed gp120-depleted HIV in Incomplete Freund's Adjuvant (IFA)," stated Ronald B Moss and colleagues from The Immune Response Corp., California. "We also reasoned that if such T helper responses were sufficient, then such a combination might also induce HIV specific CD8 T-cell immune responses."
Moss et al. presented data...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.